only beneficary from their victory will be TEVA as AMRN will give them qualified generic status in the event any generic is accepted to enter the market.
Nope … currently (IRCC) Hikma has 180-days exclusivity as a first filer. (Maybe it is Reddy … definitely one of them). As it stands now> TEVA could lauch 180 days after Hikma …